Clinical Trial Update: Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of polyethylene glycol on intestinal transit in people with cystic fibrosis and gut dysmotility; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Polyethylene Glycol (polyethylene glycol)

Snippet

Sponsor: St. Louis University | Conditions: Cystic Fibrosis Gastrointestinal Disease | Phase 4 | Status: COMPLETED | Results posted: 2024-08-09